Cyber Monday Deal: Up to 60% off InvestingProCLAIM SALE

Quidel announces definitive agreement to acquire Alere Triage Assets

Published 07/17/2017, 07:59 AM
© Reuters.  Quidel announces definitive agreement to acquire Alere Triage Assets
QDEL
-
  • Quidel Corporation (NASDAQ:QDEL) announces that it has entered into definitive agreements to acquire the Triage MeterPro cardiovascular and toxicology assets and the B-type Naturietic Peptide (BNP) assay business from Alere Inc. These products are being divested in order to obtain antitrust approvals required for Abbott’s pending acquisition of Alere.
  • The sale transactions are subject to the completion of Abbott’s acquisition of Alere.
  • Quidel will distribute the Triage MeterPro products and BNP assays through a combination of direct sales force and distributors. Transactions are expected to close by September 30.
  • Quidel will acquire the Triage and BNP business for a total consideration of $400M plus $40M in contingent consideration.
  • Now read: Celldex: Can It Succeed Just Once?


Original article

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.